International Collaboration Drives Discovery of Link Between Breast/Ovarian Cancer Gene and Stomach Cancer

Submitted by admin on Sat, 01/24/2015 - 08:23

BETHESDA, Md., Jan. 16, 2015 /PRNewswire-USNewswire/ -- A team of scientists from the United States and China has discovered new genetic insights that could change the way oncologists treat gastric cancer, the fourth most common cancer and the second leading cause of cancer death in the world. The investigators, who tested hundreds of gastric cancer tissue samples using advanced whole-genome sequencing technology, published their discovery online on January 12 in the Proceedings of National Academy of Sciences.

Program of USCACA 2014 Annual Meeting1

Submitted by admin on Tue, 06/03/2014 - 06:38

US Chinese Anti-Cancer Association Annual Meeting at ASCO 2014
6:30 - 9:00 pm
May 30, 2014
Hilton Chicago, Salon A-5, Lower Level
720 South Michigan Avenue, Chicago, 60605

USCACA president was interviewed by CCTV-america on cancer issues

Submitted by admin on Wed, 05/07/2014 - 07:25

USCACA president was interviewed by CCTV-america on cancer issues

Check the link here:
http://youtu.be/z5CybZlufQs

Call for Nomination for the USCACA-NFCR 2014 Scholar Awards

Submitted by admin on Wed, 05/07/2014 - 07:22

The USCACA and NFCR are pleased to invite nominations for the USCACA-NFCR 2014 Scholar Awards

The Awards will recognize four junior Chinese investigators on the basis of significant contributions in translational cancer research

The Awards will be presented in a ceremony during the 16th Chinese Society of Clinical Oncology (CSCO) annual meeting, September 17-21, 2014, Xiamen, China.

CMT and CSCO announce the 2013 Chinese Clinical Oncology Advances Awards

Submitted by Yunguangtong on Sun, 01/26/2014 - 05:34

The 2013 Chinese Clinical Oncology Advancement Award was recently announced. A total of 14 research programs received the award organized by China Medical Tribune (CMT) and the Chinese Society of Clinical Oncology (CSCO). These projects covered a broad spectrum of clinical oncology specialty fields and were published in prestigious journals including Lancet Oncology and Journal of Clinical Oncology. USCACA clinical oncology research experts participated the award review and selection as special panel reviewers.

Pages